ArticleDigestive diseases and sciences2026
Results of Laparoscopic Heller Myotomy in Achalasia Patients with Persistent or Recurrent Symptoms After Peroral Endoscopic Myotomy (POEM).
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPeroral endoscopic myotomy (POEM) is an effective and safe treatment for achalasia. However, in some patients symptoms may persist or recur, requiring additional treatment. The aim of this study was to examine the efficacy and safety of performing laparoscopic Heller myotomy (LHM) in achalasia patients having persistent or recurrent symptoms after POEM.
methodsThis retrospective study includes patients who underwent LHM after they failed on POEM, which was performed between August 2011 and March 2024. Follow-up data were extracted from hospital medical records, and patients completed questionnaires regarding achalasia symptoms and quality of life between March 2024 and August 2025. Primary outcome was treatment success after LHM, defined as Eckardt score ≤ 3 without subsequent retreatment.
resultsIn total, 22 patients were included (median age 43 years, 50.0% female) of which 21 completed questionnaires. Median follow-up time after LHM in patients who previously failed on POEM was 86 months. Treatment success was observed in three patients (13.6%, n = 3/22), with follow-up of 36, 74 and 110 months after LHM. A marked decline in success rate of LHM following POEM was observed over time: approximately 70% after one year and 30% after two years. For patients with treatment failure after LHM, 73.7% required retreatment (n = 14/19), predominantly with pneumatic dilation.
conclusionLHM following POEM yields only minimal benefit with a rapid loss of success over time. These outcomes suggest limited clinical value of LHM following POEM failure and indicate that alternative strategies may be preferable.
Indexed as
Identifiers
42487043What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.